Welcome to LookChem.com Sign In|Join Free

CAS

  • or

161249-56-5

Post Buying Request

161249-56-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

161249-56-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 161249-56-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,2,4 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 161249-56:
(8*1)+(7*6)+(6*1)+(5*2)+(4*4)+(3*9)+(2*5)+(1*6)=125
125 % 10 = 5
So 161249-56-5 is a valid CAS Registry Number.

161249-56-5Relevant articles and documents

Design, synthesis, and evaluation of curcumin-derived arylheptanoids for glioblastoma and neuroblastoma cytotoxicity

Campos, Catherine A.,Gianino, Joseph B.,Bailey, Barbara J.,Baluyut, Mary E.,Wiek, Constanze,Hanenberg, Helmut,Shannon, Harlan E.,Pollok, Karen E.,Ashfeld, Brandon L.

, p. 6874 - 6878 (2013)

Using an innovative approach toward multiple carbon-carbon bond-formations that relies on the multifaceted catalytic properties of titanocene complexes we constructed a series of C1-C7 analogs of curcumin for evaluation as brain and peripheral nervous system anti-cancer agents. C2-Arylated analogs proved efficacious against neuroblastoma (SK-N-SH & SK-N-FI) and glioblastoma multiforme (U87MG) cell lines. Similar inhibitory activity was also evident in p53 knockdown U87MG GBM cells. Furthermore, lead compounds showed limited growth inhibition in vitro against normal primary human CD34+hematopoietic progenitor cells. Taken together, the present findings indicate that these curcumin analogs are viable lead compounds for the development of new central and peripheral nervous system cancer chemotherapeutics with the potential for little effects on normal hematopoietic progenitor cells.

NITRIC OXIDE DONOR NEPRILYSIN INHIBITORS

-

, (2014/01/07)

In one aspect, the invention relates to compounds having the formula: where R1, R2, R3, R7, R8, Z, X, b, and c are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds are nitric oxide donors and have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.

Tandem phenolic oxidative amidation-intramolecular diels-alder reaction: An approach to the himandrine core

Liang, Huan,Ciufolini, Marco A.

supporting information; experimental part, p. 1760 - 1763 (2010/10/21)

An oxidative cyclization of dienic sulfonamides mediated by iodobenzene diacetate in TFA, followed by a tandem intramolecular Diels-Alder reaction, achieves desymmetrization of a "locally symmetrical" dienone with good levels of diastereoselectivity and leads to valuable synthetic intermediates for the himandrine alkaloids.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 161249-56-5